ETHACRYNATE SODIUM (Par Pharmaceutical, Inc.)


Welcome to the PulseAid listing for the ETHACRYNATE SODIUM drug offered from Par Pharmaceutical, Inc.. This Increased Diuresis at Loop of Henle [PE],Loop Diuretic [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Par Pharmaceutical, Inc.
NON-PROPRIETARY NAME: ethacrynate sodium
SUBSTANCE NAME: ETHACRYNATE SODIUM
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Increased Diuresis at Loop of Henle [PE],Loop Diuretic [EPC]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, POWDER, FOR SOLUTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2016-05-19
END MARKETING DATE: 0000-00-00


ETHACRYNATE SODIUM HUMAN PRESCRIPTION DRUG Details:

Item DescriptionETHACRYNATE SODIUM from Par Pharmaceutical, Inc.
LABELER NAME: Par Pharmaceutical, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 50(mg/50mL)
START MARKETING DATE: 2016-05-19
END MARKETING DATE: 0000-00-00
PRODUCT ID: 42023-157_a58bf27f-6d3b-487b-ae98-4ea759fa2ee6
PRODUCT NDC: 42023-157
APPLICATION NUMBER: ANDA205473

Other ETHACRYNATE SODIUM Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Aton Pharma, Inc.Sodium Edecrin
Mylan Institutional LLCEthacrynic Sodium
Oceanside Pharmaceuticalsethacrynic sodium
Par Pharmaceutical, Inc.ETHACRYNATE SODIUM